Dosimetric comparison of four new design {sup 103}Pd brachytherapy sources: Optimal design using silver and copper rod cores
Four new brachytherapy sources, IRA1-{sup 103}Pd, IRA2-{sup 103}Pd, IRA3-{sup 103}Pd, and IRA4-{sup 103}Pd, have been developed at Agricultural, Medical, and Industrial Research School and are designed for permanent implant application. With the goal of determining an optimal design for a {sup 103}Pd source, this article compares the dosimetric properties of these sources with reference to the authors' earlier IRA-{sup 103}Pd source. The four new sources differ in end cap configuration and thickness and in the core material, silver or copper, that carries the adsorbed {sup 103}Pd. Dosimetric data derived from the authors' Monte Carlo simulation results are reported in accordance with the updated AAPM Task Group No. 43 report (TG-43U1). For each source, the authors obtained detailed results for the dose rate constant {Lambda}, the radial dose function g(r), the anisotropy function F(r,{theta}), and the anisotropy factor {phi}{sub an}(r). In this study, the optimal source IRA3-{sup 103}Pd provides the most isotropic dose distribution in water with the dose rate constant of 0.678({+-}0.1%) cGy h{sup -1} U{sup -1}. The IRA3-{sup 103}Pd design has a silver rod core combined with thin-wall, concave end caps. Finally, the authors compared the results for their optimal source with published results for those of other source manufacturers.